Linde India Ltd

₹ 6,200 0.14%

29 Sep - close price

lindeindia.in BSE: 523457 NSE: LINDEINDIA

About

Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.^[1]

Key Points

Business Segments:^[1]
a) Gases, Related Products & Services (78% in Q1 FY27 vs 87% in Q1 FY26):^[2]
The company supplies industrial and specialty gases such as oxygen, nitrogen, and argon through onsite pipeline systems, bulk liquid distribution networks, and packaged gas solutions. Its healthcare portfolio caters to hospitals and healthcare providers by offering medical gases and associated solutions.
b) Project Engineering Division (22% in Q1 FY26 vs 13% in Q1 FY26):^[3]
The company offers turnkey engineering solutions for cryogenic gases, including the design, supply, installation, and commissioning of medium- to large-sized Air Separation Units (ASUs), nitrogen plants, and gas distribution networks. The division also manufactures cryogenic equipment such as distillation columns, cold boxes, cryogenic vessels,
and vaporizers for both internal use and
external customers.

Website BSE NSE

Market Cap ₹ 52,855 Cr.
Current Price ₹ 6,200
High / Low ₹ 8,049 / 5,653
Stock P/E 96.7
Book Value ₹ 500
Dividend Yield 0.06 %
ROCE 18.2 %
ROE 13.6 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 21.6%

Cons

Stock is trading at 12.4 times its book value
The company has delivered a poor sales growth of 11.5% over past five years.
Company has a low return on equity of 13.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Industrial Gases

Part of BSE 500 BSE 200 BSE Dollex 200 Nifty 500 Nifty MNC BSE Commodities BSE 150 MidCap Index BSE 250 LargeMidCap Index BSE 400 MidSmallCap Index Nifty LargeMidcap 250 Nifty 500 Multicap 50:25:25 Nifty Midcap 150 Nifty MidSmallcap 400 Nifty India Manufacturing Nifty Total Market Nifty500 Shariah Nifty Midcap150 Momentum 50 BSE 200 Equal Weight Nifty Midsmallcap400 Momentum Quality 100 Nifty500 Equal Weight Nifty500 LargeMidSmall Equal-Cap Weighted BSE 1000 Nifty Chemicals Nifty MidSmallcap400 50:50

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	721	711	706	630	653	634	606	592	571	644	701	614	694
	557	538	520	452	469	456	414	382	374	362	444	441	494
Operating Profit	164	174	186	179	184	179	192	210	197	282	257	173	201
OPM %	23%	24%	26%	28%	28%	28%	32%	35%	34%	44%	37%	28%	29%
	20	21	25	19	21	18	22	13	6	6	55	7	7
Interest	1	1	1	4	2	2	2	7	3	3	6	3	6
Depreciation	49	50	51	52	51	52	55	56	56	56	62	61	62
Profit before tax	134	143	159	142	152	143	157	161	144	228	245	116	140
Tax %	25%	24%	25%	26%	25%	26%	26%	27%	26%	25%	21%	33%	25%
	100	109	120	105	114	106	116	118	107	171	193	77	105
EPS in Rs	11.71	12.75	14.08	12.36	13.33	12.48	13.64	13.88	12.57	20.05	22.67	9.08	12.26
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023 15m	Mar 2024	Mar 2025	Mar 2026	TTM
	1,825	2,033	2,192	1,762	1,471	2,112	3,136	2,769	2,485	2,531	2,654
	1,539	1,705	1,866	1,347	1,096	1,564	2,371	2,066	1,720	1,622	1,741
Operating Profit	287	328	326	415	375	548	765	702	765	909	913
OPM %	16%	16%	15%	24%	25%	26%	24%	25%	31%	36%	34%
	40	8	15	862	36	335	113	85	75	74	75
Interest	116	116	103	86	6	3	6	7	13	14	17
Depreciation	195	206	199	177	176	181	253	201	214	235	241
Profit before tax	16	13	39	1,013	229	698	618	579	614	733	729
Tax %	-20%	-21%	35%	28%	34%	27%	13%	25%	26%	25%
	19	16	26	727	151	507	538	434	455	549	546
EPS in Rs	2.23	1.90	3.01	85.27	17.72	59.47	63.09	50.90	53.33	64.37	64.06
Dividend Payout %	34%	53%	50%	12%	17%	23%	19%	24%	22%	19%

Compounded Sales Growth
10 Years:	%
5 Years:	11%
3 Years:	-7%
TTM:	10%

Compounded Profit Growth
10 Years:	%
5 Years:	30%
3 Years:	1%
TTM:	22%

Stock Price CAGR
10 Years:	33%
5 Years:	19%
3 Years:	1%
1 Year:	0%

Return on Equity
10 Years:	10%
5 Years:	14%
3 Years:	13%
Last Year:	14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	85	85	85	85	85	85	85	85	85	85
Reserves	1,356	1,365	1,377	2,087	2,149	2,630	3,055	3,383	3,735	4,181
	1,445	1,282	1,199	108	7	24	22	21	42	79
	722	680	759	970	1,045	1,277	1,238	1,316	1,280	1,463
Total Liabilities	3,608	3,412	3,420	3,250	3,286	4,017	4,400	4,805	5,143	5,808
	2,573	2,498	2,162	2,035	1,989	1,869	1,762	1,822	1,925	2,093
CWIP	80	36	44	53	17	68	225	483	975	1,343
Investments	61	58	0	0	4	9	32	50	74	82
	895	821	1,214	1,162	1,276	2,071	2,380	2,450	2,168	2,291
Total Assets	3,608	3,412	3,420	3,250	3,286	4,017	4,400	4,805	5,143	5,808

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	293	252	376	327	339	589	629	437	584	786
	-128	-59	-73	981	-54	98	-306	-539	-1,305	-705
	-80	-261	-216	-1,193	-201	-28	-119	-105	-112	-116
Net Cash Flow	85	-68	87	115	84	659	203	-208	-833	-35
Free Cash Flow	160	184	286	276	296	454	280	-127	-739	25
CFO/OP	104%	79%	118%	82%	98%	121%	107%	84%	101%	109%

Ratios

Consolidated / View Standalone

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	71	63	61	79	101	73	47	63	57	73
Inventory Days	102	91	66	57	72	37	22	32	69	79
Days Payable	447	348	293	327	477	312	156	235	349	370
Cash Conversion Cycle	-274	-194	-166	-190	-303	-202	-87	-139	-224	-217
Working Capital Days	-70	-69	-73	-25	12	-3	-9	-11	-29	-40
ROCE %		5%	5%	10%	10%	17%	21%	17%	17%	18%

Insights

In beta

Dec 2014

Dec 2015

Dec 2016

Dec 2017

Dec 2018

Dec 2019

Dec 2020

Dec 2021

Mar 2023

Mar 2024

Mar 2025

Gases Revenue Share
% ・Standalone data

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
		xx.xx	xx.xx		xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
		xx				xx	xx	xx	xx	xx
	x,xxx.xx					xx,xxx.xx	xx,xxx.xx	xx,xxx.xx	xx,xxx.xx	xx,xxx.xx
						xxx	x,xxx		xxx	xxx

Please log in to see hidden values.

Top 2 Customer Revenue Share
% ・Standalone data

Number of Operating Plants
count ・Standalone data

PED Order Book
INR million ・Standalone data

Medical Oxygen Daily Delivery
TPD ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%
	2.89%	2.25%	2.31%	3.03%	2.42%	2.27%	2.63%	2.51%	2.35%	2.03%	2.05%	2.03%
	7.44%	7.22%	7.45%	6.84%	6.88%	6.81%	6.49%	6.62%	6.75%	6.95%	6.88%	6.79%
	14.67%	15.52%	15.23%	15.13%	15.70%	15.92%	15.90%	15.87%	15.90%	16.02%	16.08%	16.17%
No. of Shareholders	49,724	54,661	52,221	60,138	63,324	66,819	67,569	68,796	68,078	66,620	63,167	63,024

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	75.00%	75.00%	75.00%	75.03%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%
	5.82%	2.93%	1.54%	1.98%	1.62%	2.59%	2.77%	2.31%	2.63%	2.05%	2.03%
	10.31%	13.05%	13.83%	13.02%	11.42%	8.31%	8.01%	7.45%	6.49%	6.88%	6.79%
	8.87%	9.02%	9.63%	9.97%	11.96%	14.10%	14.23%	15.23%	15.90%	16.08%	16.17%
No. of Shareholders	19,627	21,084	20,131	19,537	23,783	48,537	44,457	52,221	67,569	63,167	63,024

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

Aug 2025

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
Aug 2023

Transcript

AI Summary
PPT
Jun 2022

Transcript

AI Summary
PPT
Jun 2021

Transcript

AI Summary
PPT
Sep 2020

Transcript

AI Summary
PPT
Sep 2017

Transcript

AI Summary
PPT
Feb 2016

Transcript

AI Summary
PPT
Dec 2014

Transcript

AI Summary
PPT
Jul 2014

Transcript

AI Summary
PPT
Dec 2013

Transcript

AI Summary
PPT
Jul 2013

Transcript

AI Summary
PPT